Baidu
map

Science:新发现生长因子PIGF-2可加速伤口愈合再生

2014-02-26 中国科技网 中国科技网

杀死比尔剧照 新华社日内瓦2月24日电 瑞士洛桑联邦工学院的科研人员日前发表研究公报称,一种名为“PIGF-2”的生长因子可以大大促进机体组织的生长,加速伤口愈合。这一发现将有助于再生药物研究。人体受伤后通常会自我修复受损组织,这一过程是由一种被称为生长因子的蛋白质所控制的。细胞内的生长因子可以加速伤口愈合,避免失血过多及并发症,对胚胎发育也很重要。   生长因子则是通过聚合一


杀死比尔剧照

瑞士洛桑联邦工学院的科研人员日前发表研究公报称,一种名为“PIGF-2”的生长因子可以大大促进机体组织的生长,加速伤口愈合。这一发现将有助于再生药物研究。

人体受伤后通常会自我修复受损组织,这一过程是由一种被称为生长因子的蛋白质所控制的。细胞内的生长因子可以加速伤口愈合,避免失血过多及并发症,对胚胎发育也很重要。   生长因子则是通过聚合一种名为“细胞外基质”的蛋白质来促进机体组织细胞的生长。细胞外基质好比机体组织的“框架”,通常情况下,生长因子聚合细胞外基质的能力越强,伤口愈合得越快。但目前含有生长因子成分的药物却往往效果不佳,无法到达天然生长因子在人体内的修复效果。   洛桑联邦工学院教授杰弗里·哈贝尔领导的研究小组对25种生长因子进行了动物实验,结果发现,“PIGF-2”生长因子对细胞外基质的聚合能力最强,促进组织器官修复的效率最高。   研究人员将一部分“PIGF-2”生长因子与其他三种修复效率较低的生长因子相融合,结果发现,它们对细胞外基质的聚合能力增加了近100倍,从而在未来或可大大减少生长因子药物的使用剂量。此外,经过生物工程技术处理而相互融合的生长因子,能加快血液凝块结痂,进一步提高伤口愈合效果。   目前研究人员仅对实验鼠进行了动物研究,他们还将展开更多的动物实验,并最终用于人体。这一研究成果已发表在新一期的美国《科学》杂志上。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]
    2014-10-28 wbz951729

    当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]
    2014-10-28 wbz951729

    本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]
    2014-03-25 xxxx1049
  5. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]
    2014-02-28 jichang
  7. [GetPortalCommentsPageByObjectIdResponse(id=12349, encodeId=c5341234960, content=当人体受伤时体内的组织生长因子水平,是否很高。伤后一周内不需要补充。这个观点对吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:42:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12348, encodeId=d6e21234886, content=本刊发表的论文,均是现代医学学术前沿,很新颖。我深感兴趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0a1604518, createdName=wbz951729, createdTime=Tue Oct 28 09:39:00 CST 2014, time=2014-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921095, encodeId=8d86192109511, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jan 31 05:04:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039521, encodeId=645a2039521c1, content=<a href='/topic/show?id=ca1294914d' target=_blank style='color:#2F92EE;'>#IGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9491, encryptionId=ca1294914d, topicName=IGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Tue Mar 25 21:04:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309844, encodeId=cc8a1309844ea, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374837, encodeId=4b5413e483715, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517940, encodeId=561c151e94055, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Fri Feb 28 02:04:00 CST 2014, time=2014-02-28, status=1, ipAttribution=)]

相关资讯

ASCO 2013:联用生长因子可改善伊匹单抗针对黑色素瘤的疗效

伊利诺斯州芝加哥市消息-一项临床2期研究结果显示,伊匹单抗联用某种生长因子时,产生的协同治疗效应似乎可以改善某些转移性黑色素瘤患者的总生存率。与伊匹单抗单药相比,患者通过伊匹单抗及生长因子沙格司亭(Leukine, Sanofi)联合治疗可获得较佳的总生存率(51.2%vs67.9%; 分层对数秩P1 = 0.016, P2 =.033)。首席作者、马萨诸塞州波士顿Dana-Farber癌症研究所

肝细胞生长因子可修复喉返神经损伤

     喉返神经损伤后,再生的轴突数目不足及功能恢复不佳是影响喉功能恢复的重要原因。应用神经营养因子等生物活性因子促进神经轴突的再生, 近年来已成为周围神经损伤修复研究中的一项重要突破。肝细胞生长因子(HGF ) 广泛分布于全身各组织器官,是一种多效性细胞因子, 具有多种功能。已有研究证实HGF 对中枢神经系统有保护作用 ,&n

Cancer Metast Rev:生长因子对肿瘤转移的作用

恶性肿瘤转移是肿瘤病人死亡的主要原因,也是当今肿瘤研究领域的焦点。肿瘤转移过程中,瘤细胞首先脱离原发瘤,侵犯并穿过宿主基质进入循环,存活并到达远处毛细血管床,在那里粘附并穿出血管,进入器官实质,增殖成继发肿瘤。 早在1889年,Paget即提出,器官微环境(“土壤”)可影响特定肿瘤细胞(“种子”)的种植、侵袭、存活、生长。肿瘤转移早期常呈现特异脏器亲合性,如结肠癌易转移到肝脏,肺癌易转移到骨、肾

CANCER RES:致命的皮肤癌如何全身扩散

  弗吉尼亚联邦大学梅西癌症中心的科学家Paul B. Fisher博士1月3号发表在《癌症》杂志上的一项研究表明:在肿瘤新血管的形成过程中,mda-9/syntenin是调节血管生成的关键因子。   这是科学家继成功在实验室试验中消除黑色素瘤转移后,又取得的又一项重要发现:黑色素瘤分化相关基因-9(mda-9/syntenin)导致了转移的恶性黑色素瘤(皮肤癌的扩散)和其他

Arthritis Rheum:抗神经生长因子治疗髋骨关节炎有效

  《关节炎与风湿病》2013年4月1日在线发表的一项Ⅲ期研究结果显示,与安慰剂相比,抗神经生长因子(抗-NGF)tanezumab治疗16周可显著改善髋关节骨关节炎(OA)患者的疼痛、身体功能以及骨关节炎患者疗效总体评分[Arthritis Rheum. 2013 April 1(doi:10.1002/art.37950)]。   Mark Brown博士及其同事报告称,这项纳入621例髋关

Baidu
map
Baidu
map
Baidu
map